Drug Profile
Ketotifen/naphazoline
Alternative Names: KetoNaph; Ketotifen fumarate/naphazoline HCl; Ketotifen fumarate/naphazoline hydrochloride; Ketotifen/naphazoline ophthalmic solution; Naphazoline/ketotifenLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Bausch & Lomb
- Class Antiallergics; Imidazoles; Sedating antihistamines; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Histamine H1 receptor antagonists; Mast cell stabilisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Allergic conjunctivitis
Most Recent Events
- 27 Nov 2015 No recent reports on development identified - Phase-III for Allergic conjunctivitis in USA (Ophthalmic)